Partial
Partially Aligned
Patient Risk:
Low
Summary
Most statements are general aspirin-use claims that are not supported or are likely not addressed in the provided prescribing-information excerpts for aspirin/extended-release dipyridamole capsules; only the core indication-related stroke-risk claim is directly supported by the supplied label text.
Category Scores
Accurate Statements
The product reduces risk of stroke in patients with prior transient ischemia of the brain (TIA) or completed ischemic stroke due to thrombosis.
Supported by Section 1 INDICATIONS AND USAGE: “indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.” Also consistent with Section 14 CLINICAL STUDIES reporting stroke risk reduction for the aspirin + extended-release dipyridamole regimen.
Unsupported Statements
V8 juice is not a known medication interaction with aspirin.
No provided label text addresses V8/food/beverage interactions.
For most people, it is generally considered fine to drink V8 juice while taking aspirin.
No provided label text addresses V8 or similar beverages.
Aspirin does not have a specific, documented incompatibility with the ingredients found in V8, such as tomato/vegetable components.
No provided label text addresses tomato/vegetable components or specific incompatibilities with foods.
Aspirin can increase stomach irritation or bleeding risk, especially at higher doses.
The provided excerpts only explicitly discuss increased bleeding risk in general (5.1) but do not provide dose-specific gastrointestinal irritation statements.
Aspirin can increase stomach irritation or bleeding risk in people with a history of ulcers.
No provided label text mentions ulcer history as a bleeding risk factor.
Aspirin can increase stomach irritation or bleeding risk when taken without food.
No provided label text addresses taking aspirin with or without food.
Aspirin can cause side effects including heartburn.
No provided label text in the excerpts lists heartburn as an adverse reaction.
Aspirin can cause side effects including stomach pain.
No provided label text in the excerpts lists stomach pain as an adverse reaction.
Aspirin can cause side effects including nausea.
No provided label text in the excerpts lists nausea as an adverse reaction.
Aspirin can cause gastrointestinal bleeding.
The provided excerpt indicates increased risk of bleeding, but the specific phrasing “gastrointestinal bleeding” as an adverse reaction is not explicitly stated in the provided excerpts.
Acidic beverages or beverages that trigger reflux/irritation can make aspirin side effects feel worse.
No provided label text addresses acidic beverages or reflux-related worsening.
V8 juice does not contain vitamin K at meaningful levels like some leafy greens do.
No provided label text addresses vitamin K content of foods.
Vitamin K is a concern for warfarin dosing.
No provided label text addresses warfarin or vitamin K considerations.
A main safety consideration for aspirin is gastrointestinal bleeding/irritation risk.
The provided excerpts discuss risk of bleeding (5.1) but do not specify gastrointestinal bleeding/irritation as the 'main' safety consideration.
Taking aspirin with food can reduce stomach irritation (unless a prescriber told not to).
No provided label text addresses administration with food to reduce irritation.
Avoid taking aspirin when already having significant reflux or stomach symptoms.
No provided label text addresses reflux/stomach symptoms as contraindications or precautions.
Combining aspirin with other irritants such as alcohol should be checked for risk.
No provided label text in the excerpts addresses alcohol.
Contradictions
Important Omissions
Any discussion of bleeding risk factors specifically listed in the provided label excerpt (e.g., interacting drugs such as anticoagulants, antiplatelet agents, heparin, anagrelide, fibrinolytic therapy, chronic NSAID use) when making broad bleeding-risk statements.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only directly label-supported claim is the stroke-risk indication. The other statements are largely unsupported by the provided label excerpts and include generalizations about foods and side effects that may not be accurately reflected in the supplied prescribing information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Most listed claims are not supported by the provided FDA label excerpts (they address V8/food interactions, reflux, and specific adverse reactions without label support in the excerpts).
Suggested Improvement
Restrict claims to label-supported content from the provided sections (e.g., stroke-risk reduction per Section 1 and bleeding risk increase per Section 5.1), and avoid making unsupported assertions about food/drink interactions and specific gastrointestinal symptoms unless that information is present in the provided prescribing information.